Fagron NV/€FAGR
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Fagron NV
Fagron NV is a pharmaceutical company specializing in pharmaceutical compounding, providing personalized medical solutions to hospitals, pharmacies, clinics, and patients across more than 30 countries. The company operates through three segments: Essentials, offering pharmaceutical raw materials and equipment; Brands, developing innovative compounding concepts and formulations; and Compounding Services, delivering ready-to-use medications from its sterile and non-sterile facilities. Founded in 1990 in Rotterdam, the Netherlands, Fagron has expanded its operations globally, with its registered office in Nazareth, Belgium, and operational headquarters in Rotterdam. The company's strategic focus on innovation and quality has enabled it to establish a significant presence in the pharmaceutical compounding market.
Ticker
€FAGR
Sector
Primary listing
BSE
Industry
Health Care Providers and Services
Headquarters
Employees
3,828
Website
Fagron NV Metrics
BasicAdvanced
€1.6B
20.07
€1.10
0.27
€0.25
1.11%
Price and volume
Market cap
€1.6B
Beta
0.27
52-week high
€22.85
52-week low
€14.97
Average daily volume
49K
Dividend rate
€0.25
Financial strength
Current ratio
1.862
Quick ratio
1.159
Long term debt to equity
74.441
Total debt to equity
76.45
Dividend payout ratio (TTM)
26.13%
Interest coverage (TTM)
7.45%
Profitability
EBITDA (TTM)
146.558
Gross margin (TTM)
45.38%
Net profit margin (TTM)
9.24%
Operating margin (TTM)
14.99%
Effective tax rate (TTM)
22.34%
Revenue per employee (TTM)
€230,000
Management effectiveness
Return on assets (TTM)
7.77%
Return on equity (TTM)
16.65%
Valuation
Price to earnings (TTM)
20.073
Price to revenue (TTM)
1.847
Price to book
3.21
Price to tangible book (TTM)
-231.05
Price to free cash flow (TTM)
23.307
Free cash flow yield (TTM)
4.29%
Free cash flow per share (TTM)
0.947
Dividend yield (TTM)
1.11%
Forward dividend yield
1.11%
Growth
Revenue change (TTM)
14.28%
Earnings per share change (TTM)
13.82%
3-year revenue growth (CAGR)
14.97%
10-year revenue growth (CAGR)
6.91%
3-year earnings per share growth (CAGR)
9.42%
10-year earnings per share growth (CAGR)
7.75%
3-year dividend per share growth (CAGR)
20.51%
10-year dividend per share growth (CAGR)
-9.97%
Bulls say / Bears say
Fagron reported a 13% organic revenue growth at constant exchange rates in Q4 2024, with total revenue reaching €172 million, indicating strong market demand and operational efficiency. (gurufocus.com)
The company announced six acquisitions between the end of 2024 and early 2025, strengthening its market position and demonstrating financial discipline. (gurufocus.com)
Fagron's proposed dividend of €0.35 per share represents a 17% increase compared to 2023, reflecting strong financial performance and commitment to shareholder returns. (gurufocus.com)
The FDA issued a warning letter to Fagron regarding its Wichita facility, with corrective actions still being implemented, which could impact operations and reputation. (gurufocus.com)
Operating costs increased by 18.6% year on year, mainly due to growth in Compounding Services in North America and the impact of acquisitions, potentially affecting profit margins. (gurufocus.com)
The competitive environment in Latin America remains challenging, which could impact Fagron's growth and profitability in the region. (finance.yahoo.com)
Data summarised monthly by Lightyear AI. Last updated on 3 Jul 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Fagron NV stock?
Fagron NV (FAGR) has a market cap of €1.6B as of July 31, 2025.
What is the P/E ratio for Fagron NV stock?
The price to earnings (P/E) ratio for Fagron NV (FAGR) stock is 20.07 as of July 31, 2025.
Does Fagron NV stock pay dividends?
Yes, the Fagron NV (FAGR) stock pays dividends to shareholders. As of July 31, 2025, the dividend rate is €0.245 and the yield is 1.11%. Fagron NV has a payout ratio of 26.13% on a trailing twelve-month basis.
When is the next Fagron NV dividend payment date?
The next Fagron NV (FAGR) dividend payment date is unconfirmed.
What is the beta indicator for Fagron NV?
Fagron NV (FAGR) has a beta rating of 0.27. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.